Is Crinetics Pharmaceuticals, Inc. (CRNX) a Buy, Sell, or Hold?
NASDAQ : CRNX
Crinetics Pharmaceuticals, Inc. — Analyst Ratings
$83.52 USD
-$0.11 (-0.13%)
- Volume
- 1.86M
- Average Volume
- 3.69M
- Market Capitalization
- $8.84B
- P/E Ratio
- -16.25
- Dividend Yield
- 0.00%
- Price Target
- $85.00
- Year High
- $84.00
- Year Low
- $25.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.60
Analyst Consensus Summary
Consensus Rating
Sell
21 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-1.7%
vs Current Price
Price Target
$85.00
Average TargetPrice Target Range
Lowest Target
$84.00
-0.6% DOWNSIDE
Average Target
$85.00
Median Estimate
Highest Target
$85.00
-1.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 21
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 13 | 8 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Alex Thompson | $85 | $83.5 | 2026-07-08 09:15 AM | 1.8% |
| UBS | Ashwani Verma | $55 | $38.68 | 2026-07-02 04:38 AM | 42.2% |
| Stifel Nicolaus | Alex Thompson | $83 | $36.06 | 2026-06-22 09:34 AM | 130.2% |
| H.C. Wainwright | Douglas Tsao | $81 | $34.47 | 2026-06-15 06:48 AM | 135.0% |
| Evercore ISI | Gavin Clark-Gartner | $88 | $37.71 | 2026-05-15 08:22 AM | 133.4% |